R3 Acetabular
Payments companies reported to CMS as associated with R3 Acetabular. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with R3 Acetabular, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with R3 Acetabular
These are the largest totals companies reported as associated with R3 Acetabular. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Thorsten Seyler | Durham, NC | Adult Reconstructive Orthopaedic Surgery | $210,342.25 |
| Mathias Bostrom | White Plains, NY | Orthopaedic Surgery | $100,384.22 |
| George Haidukewych | Orlando, FL | Orthopaedic Surgery | $84,478.13 |
| Steven Haas | New York, NY | Orthopaedic Surgery | $79,960.77 |
| Edwin Su | New York, NY | Orthopaedic Surgery | $74,815.57 |
| Ran Schwarzkopf | Orange, CA | $72,613.02 | |
| Stephen Duncan | Lexington, KY | Adult Reconstructive Orthopaedic Surgery | $68,168.54 |
| William Lutes | Kenosha, WI | Adult Reconstructive Orthopaedic Surgery | $45,677.83 |
| Adam Rana | Falmouth, ME | Orthopaedic Surgery | $44,247.83 |
| Chancellor Gray | Gainesville, FL | Adult Reconstructive Orthopaedic Surgery | $28,600.95 |
Prescribed R3 Acetabular?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.